-transparent.png){kind=logo}
It was found that Fluosol-DA 20% relieves human acute cerebral ischemia resulting from vasospasm in 62% of the cases. However, several problems were encountered during the investigation. The efficacy of the solution was temporary, that is, within 24 hours. This is considered logical because perfluorochemical particles are eliminated fairly rapidly from the circulating blood. Successive administrations should be necessary until cerebral vasospasm is remitted. Another problem is that it is not clear whether the doses of the solution given in this study (10 ml/kg/day) are sufficient or not, since the depth of the cerebral ischemia is considered to vary depending on the case. It might be necessary to change the volume of the solution given in accordance with the depth of the ischemia of each patient.
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
January 1981,
Stroke,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
January 1992,
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
December 1981,
No shinkei geka. Neurological surgery,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
January 1984,
Stroke,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
June 1984,
JAMA,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
December 1981,
Neurologia medico-chirurgica,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
January 1983,
Progress in clinical and biological research,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
March 1990,
Neurological research,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
January 1985,
Advances in experimental medicine and biology,
H Handa, and
S Nagasawa, and
Y Yonekawa, and
Y Naruo, and
Y Oda
June 1987,
Cancer research,
